Keith Geraghty

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:www.researchgate.net

Dr. Keith Geraghty, B.Sc., B.Sc., M.Dip., M.P.H., Ph.D., is a Honorary Research Fellow at the University of Manchester (UK) in the Centre for Primary Care. His main research interests are patient safety and harms, doctor-patient relations, medically unexplained illness and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).[1] He holds a Ph.D. in Health Management, a Master of Public Health (Merit with award of Distinction in Dissertation) and a Master Postgraduate Diploma in Research Methodology.[2] In addition to being a ME/CFS researcher, Dr. Geraghty lives with ME/CFS.

In 2012, Geraghty became the Founder Director of The ME/CFS Research Group, whose goal is to bring together researchers and clinicians to undertake innovative studies of ME/CFS.[3]

Geraghty serves on the editorial board of the journal, Fatigue: Biomedicine, Health & Behavior.[4]

Publications[edit | edit source]

2015[edit | edit source]

2016[edit | edit source]

2017[edit | edit source]

2018[edit | edit source]

  • 2018, Rethinking the treatment of chronic fatigue syndrome—A reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT[16](Full text)
  • 2018, Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter[17](Full text)
  • 2018, Are ME/CFS Patient Organizations “Militant”?[18](Abstract)

2019[edit | edit source]

  • 2019, The Importance of Accurate Diagnosis of ME/CFS in Children and Adolescents: A Commentary[19](Full text)
  • 2019, The 'Cognitive Behavioural Model' of Chronic Fatigue Syndrome: Critique of a Flawed Model[20](Abstract)
  • 2019, A logistic regression analysis of risk factors in ME/CFS pathogenesis[21] - (Full text)

Talks, interviews and blogs[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]


Learn more[edit | edit source]

References[edit | edit source]

  1. IACFS. "May 2016 Newsletter | Dr Keith Geraghty Doing CFS Research". 
  2. The University of Manchester. "Dr Keith Geraghty M.Dip., M.P.H., Ph.D. | The University of Manchester". www.manchester.ac.uk. Retrieved Nov 2, 2018. 
  3. "Keith Geraghty". linkedin.com. 
  4. "Fatigue: Biomedicine, Health & Behavior". www.tandfonline.com. Retrieved Nov 1, 2019. 
  5. Twisk, Frank; Geraghty, Keith (Nov 11, 2015). "Deviant Cellular and Physiological Responses to Exercise in Myalgic Encephalomyelitis and Chronic Fatigue Syndrome". Jacobs Journal of Physiology. 1 (2): 007. doi:10.1177/1359105316667798. 
  6. http://iacfsme.org/PDFS/2016MayNesletter/Attachment-08-Dr-Keith-Geraghty-Doing-CFS-research.aspx
  7. Geraghty, Keith (Jun 27, 2016). "The 'all in the mind' myth of myalgic encephalomyelitis/chronic fatigue syndrome". Nursing in Practice. 
  8. Geraghty, Keith; Esmail, Aneez (Aug 1, 2016). "Chronic fatigue syndrome: is the biopsychosocial model responsible for patient dissatisfaction and harm?". British Journal of General Practice. 66 (649): 437-438. doi:10.3399/bjgp16X686473. 
  9. Blease, Charlotte; Geraghty, Keith (Sep 15, 2016). "Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent". Journal of Health Psychology. doi:10.1177/1359105316667798. 
  10. Geraghty, Keith (Sep 23, 2016). "'PACE-Gate': When clinical trial evidence meets open data access". Journal of Health Psychology. PMID 27807258. 
  11. Blease, Charlotte; Geraghty, Keith (Dec 6, 2016). "Mind the Gap: Ethical Failures in the Treatment of Chronic Fatigue Syndrome" (Journal of Medical Ethics blog). 
  12. Blease, Charlotte; Havi, Carel; Geraghty, Keith (Dec 5, 2016). "Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome". Journal of Medical Ethics. 2017 (43): 549-557. doi:10.1136/medethics-2016-103691. PMID 27920164. 
  13. Geraghty, Keith. "Dr Keith Geraghty MPH, PhD". University of Manchester. Retrieved Mar 30, 2019. 
  14. Geraghty, Keith (May 2017). "Further Commentary on the PACE Trial: Biased Methods and Unreliable Outcomes". Journal of Health Psychology. doi:10.1177/1359105317714486. 
  15. Geraghty, Keith; Hann, Mark; Kurtev, Stoyan (Aug 29, 2017). "Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys". Journal of Health Psychology. doi:10.1177/1359105317726152. 
  16. Wilshire, C; Kindlon, T; Courtney, R; Matthees, A; Tuller, D; Geraghty, K; Levin, B (2018). "Rethinking the treatment of chronic fatigue syndrome—A reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT". ResearchGate. 
  17. Geraghty, Keith J.; Blease, Charlotte (Jun 2018). "Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter". Disability and Rehabilitation. doi:10.1080/09638288.2018.1481149. 
  18. Blease, Charlotte; Geraghty, Keith (July 2018). "Are ME/CFS Patient Organizations "Militant"?". Bioethical Inquiry. doi:10.1007/s11673-018-9866-5. 
  19. Adeniji, Charles; Geraghty, Keith James (2019). "The Importance of Accurate Diagnosis of ME/CFS in Children and Adolescents: A Commentary". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00435. ISSN 2296-2360. 
  20. Geraghty, Keith; Jason, Leonard; Sunnquist, Madison; Blease, Charlotte; Tuller, David; Adeniji, Charles (Jan 1, 2019). "The 'Cognitive Behavioural Model' of Chronic Fatigue Syndrome: Critique of a Flawed Model. Journal of Health Psychology". Journal of Health Psychology. 
  21. Lacerda, Eliana M.; Geraghty, Keith; Kingdon, Caroline C.; Palla, Luigi; Nacul, Luis (Dec 2019). "A logistic regression analysis of risk factors in ME/CFS pathogenesis". BMC Neurology. 19 (1): 275. doi:10.1186/s12883-019-1468-2. ISSN 1471-2377. 
  22. Blease, Charlotte; Geraghty, Keith (Dec 6, 2016). "Mind the Gap: Ethical Failures in the Treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". BMJ blog. Retrieved Dec 4, 2018. 

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

Cognitive behavioral therapy (CBT) - A type of psychotherapy geared toward modifying alleged unhealthy thinking, behaviors or illness beliefs. One of the treatment arms used in the controversial PACE trial.

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Biopsychosocial model (BPS) - A school of thought, usually based in psychology, which claims illness and disease to be the result of the intermingling of biological, psychological and social causes. (Learn more: en.wikipedia.org)

Accuracy - The "closeness of an observation to the true clinical state". With respect to diagnostic tests, "accuracy" means how specific and sensitive the test is.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.